Dr. Jan Tesarik obtained his MD degree in 1979 and PhD in 1982. He realized the world´s first successful Gamete Intra-Fallopian Transfer (GIFT), in 1982, and the first childbirths after oocyte fertilization with round spermatids (ROSI) and with in-vitro cultured elongating spermatids (ELSI) in 1995 and 1998, respectively. He developed an original technique for nuclear transfer in mature human oocytes (2000), currently popular as the “3-parent-baby technique”. He described beneficial effects of growth hormone (GH) on oocyte quality in women of >40 years old, and younger women suffering from polycystic ovary syndrome. He also showed a beneficial effect of GH on uterine receptivity in women with recurrent implantation failure. He developed several original virtual imaging endoscopy techniques, based on ultrasound scan, including virtual hysteroscopy, virtual salpingoscopy, virtual embryoscopy and virtual folliculoscopy. Since the outbreak of the coronavirus disease-19 (COVID-19) pandemic, he was investigating into different anti-COVID agents, with particular reference to the preservation of fertility and protection of pregnant women. He is author of >400 scientific publications (articles and book chapters) and editor of 2 books. He worked at the Purkyne University (Brno, Czechoslovakia) and later at the American Hospital of Paris (France). At present he is Director of MARGen (Molecular Asssisted Reproduction and Genetics) Clinic in Granada (Spain).